CASE STUDY: Leveraging Technology and Clinical Trial Data Sources to Improve eTMF Quality
Merck has large global clinical trials that are operating in multiple countries around the world. Many of these countries are using our consent documents in two or three different language to accommodate their patient population. This presents many challenges in the TMF, as well as challenges for the US based HQ team that is not multilingual. The initiative leverages technology to integrate various clinical trial data sources, to improve the quality and functionality of the TMF.